Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
ACS Medicinal Chemistry Letters
|
November 17, 2022
Discovery of 5,7-Dihydro-6<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors
Alexander Sokolsky, Sarah Winterton, Keith Kennedy, et al.
Molecular Cancer Therapeutics
|
July 17, 2014
Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo
Yi-Xiang Zhang, Ewa Sicinska, Jeffrey T Czaplinski, et al.
Scientific Data
|
June 28, 2020
Building a PubMed knowledge graph
Jian Xu, Sunkyu Kim, Min Song, et al.
JCO Clinical Cancer Informatics
|
August 16, 2024
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer
Sunkyu Kim, Seung-Seob Kim, Eejung Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia
Yana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Oncotarget
|
November 17, 2018
The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models
Sunkyu Kim, Ralph Tiedt, Alice Loo, et al.
Oncotarget
|
April 16, 2020
Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models
Sunkyu Kim, Ralph Tiedt, Alice Loo, et al.
The Journal of Biological Chemistry
|
October 10, 2003
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors
Harry Towbin, Kenneth W Bair, James A DeCaprio, et al.
Journal of Medicinal Chemistry
|
September 20, 2025
Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ)
Ming Xiang, Shicheng Shi, Shaoqun Qian, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 28, 2023
Unusual Raman Enhancement Effect of Ultrathin Copper Sulfide
Gwangwoo Kim, Du Won Jeong, Geonhee Lee, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
ACS Medicinal Chemistry Letters
|
November 17, 2022
Discovery of 5,7-Dihydro-6<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors
Alexander Sokolsky, Sarah Winterton, Keith Kennedy, et al.
Molecular Cancer Therapeutics
|
July 17, 2014
Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo
Yi-Xiang Zhang, Ewa Sicinska, Jeffrey T Czaplinski, et al.
Scientific Data
|
June 28, 2020
Building a PubMed knowledge graph
Jian Xu, Sunkyu Kim, Min Song, et al.
JCO Clinical Cancer Informatics
|
August 16, 2024
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer
Sunkyu Kim, Seung-Seob Kim, Eejung Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic Leukemia
Yana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Oncotarget
|
November 17, 2018
The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models
Sunkyu Kim, Ralph Tiedt, Alice Loo, et al.
Oncotarget
|
April 16, 2020
Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models
Sunkyu Kim, Ralph Tiedt, Alice Loo, et al.
The Journal of Biological Chemistry
|
October 10, 2003
Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors
Harry Towbin, Kenneth W Bair, James A DeCaprio, et al.
Journal of Medicinal Chemistry
|
September 20, 2025
Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ)
Ming Xiang, Shicheng Shi, Shaoqun Qian, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
December 28, 2023
Unusual Raman Enhancement Effect of Ultrathin Copper Sulfide
Gwangwoo Kim, Du Won Jeong, Geonhee Lee, et al.
Page
of 7